Position in A
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$12,618
+$6,350 QoQ
Shares Held
95
+72.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#988
of 1,112 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Avion Wealth holds $501,324 across 17 Diagnostics & Research names. A ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
743 | $372,510 | |
| 2 | DGX |
Quest Diagnostics Inc
|
103 | $21,830 | |
| 3 | DHR |
Danaher Corp /De/
|
89 | $16,952 | |
| 4 | WAT |
Waters Corp /De/
|
38 | $14,251 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
73 | $14,105 | |
| 6 | ILMN |
Illumina, Inc.
|
72 | $12,659 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
24 | $12,634 | |
| 8 | A |
Agilent Technologies, Inc.
This page
|
95 | $12,618 |
All Filings in A
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,618 | 95 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $6,268 | 55 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $8,572 | 63 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $8,599 | 67 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $8,496 | 72 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $5,849 | 50 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $6 | 50 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $7 | 52 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $6 | 51 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $6,402 | 44 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,144 | 37 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $561 | 29 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $962 | 8 | Shares | Sole | 2023-07-14 | |
| No filing history on record for this holder in this stock. | ||||||